Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected Infants

Antiretroviral (ARV) drugs are routinely provided to HIV-infected pregnant women to prevent HIV mother-to-child transmission. Although ARV use has significantly reduced mother-to-child transmission to

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2010-02, Vol.125 (2), p.e250-e260
Hauptverfasser:	Williams, Paige L, Marino, Miguel, Malee, Kathleen, Brogly, Susan, Hughes, Michael D, Mofenson, Lynne M, PACTG 219C Team
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents - therapeutic use Antiretroviral drugs Babies Brain Child Development Confounding Factors, Epidemiologic Female HIV HIV Infections - drug therapy HIV Infections - transmission HIV-1 Human immunodeficiency virus Humans Infant Infant, Newborn Infectious Disease Transmission, Vertical - prevention & control Logistic Models Male Maternal & child health Pediatrics Pregnancy Pregnancy Complications, Infectious - drug therapy Prenatal Exposure Delayed Effects - epidemiology Reverse Transcriptase Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Antiretroviral (ARV) drugs are routinely provided to HIV-infected pregnant women to prevent HIV mother-to-child transmission. Although ARV use has significantly reduced mother-to-child transmission to
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.2009-1112